OTC · CIK 0000879911
AERG APPLIED ENERGETICS, INC.
Insider trading from SEC Form 4. Last filing 7 d ago. Close $0.84 on Oct 9, 2026, +23% from the 52-week low and -61% from the high.
APPLIED ENERGETICS, INC. (AERG) has 37 SEC Form 4 filings on file from 4 insiders, the latest filed on Oct 6, 2026. No insider bought or sold on the open market in the last 90 days; rows filed in that time are grants, exercises, tax withholding and other transactions that carry no view on the price.
33 open-market trades have been scored at AERG. The newest: Bradford Thomas Adamczyk (Executive Chairman) sold $15k of stock on Jun 8, 2026, filed Jun 10, 2026, scored 0 (weak), under a 10b5-1 plan. The largest of the 33 shown: Bradford Thomas Adamczyk (Executive Chairman) sold $23k on Jul 15, 2025, scored 0 (weak), under a 10b5-1 plan. 2 insiders sold within 14 days of each other around Jun 8, 2026.
AERG closed at $0.84 on Oct 9, 2026, 23% above its 52-week low and 61% below its 52-week high.
Last 90 days
Price and insider trades, last year
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
Open-market buys and sells at APPLIED ENERGETICS, INC., scored.
| Score | Insider | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 0Weak | Bradford Thomas Adamczyk Executive Chairman sell | $15k 10,000 shares | -1% | +50% from low-41% from high | |
| 13Weak | Christopher Wayne Donaghey President & CEO sell | $15k 10,000 shares | -8% | +62% from low-44% from high | |
| 0Weak | Bradford Thomas Adamczyk Executive Chairman sell | $15k 10,000 shares | -1% | +111% from low-45% from high | |
| 13Weak | Christopher Wayne Donaghey President & CEO sell | $15k 10,000 shares | -7% | +111% from low-45% from high | |
| 20Weak | Christopher Wayne Donaghey President & CEO/Principal AO sell | $17k 10,000 shares | -7% | +142% from low-46% from high | |
| 25Weak | Gregory James Quarles CEO Emeritus sell | $12k 6,600 shares | -100% | +181% from low-37% from high | |
| 10Weak | Stephen William McCahon Chief Science Officer sell | $18k 10,000 shares | -0% | +173% from low-39% from high | |
| 0Weak | Bradford Thomas Adamczyk Executive Chairman sell | $18k 10,000 shares | -1% | +189% from low-35% from high | |
| 10Weak | Stephen William McCahon Chief Science Officer sell | $19k 10,000 shares | -0% | +212% from low-36% from high | |
| 20Weak | Christopher Wayne Donaghey President & CEO/Principal AO sell | $19k 10,000 shares | -7% | +229% from low-33% from high | |
| 25Weak | Gregory James Quarles CEO Emeritus sell | $19k 10,000 shares | -100% | +212% from low-36% from high | |
| 0Weak | Bradford Thomas Adamczyk Executive Chairman sell | $19k 10,000 shares | -1% | +222% from low-34% from high | |
| 25Weak | Gregory James Quarles CEO Emeritus sell | $18k 10,000 shares | -100% | +193% from low-40% from high | |
| 20Weak | Christopher Wayne Donaghey President & CEO/Principal AO sell | $15k 10,000 shares | -6% | +148% from low-50% from high | |
| 10Weak | Stephen William McCahon Chief Science Officer sell | $15k 10,000 shares | -0% | +154% from low-48% from high | |
| 0Weak | Bradford Thomas Adamczyk Executive Chairman sell | $16k 10,000 shares | -1% | +149% from low-49% from high | |
| 13Weak | Christopher Wayne Donaghey President & CEO/Principal AO sell | $17k 10,000 shares | -6% | +196% from low-40% from high | |
| 3Weak | Stephen William McCahon Chief Science Officer sell | $17k 10,000 shares | -0% | +204% from low-38% from high | |
| 20Weak | Christopher Wayne Donaghey President & CEO/Principal AO sell | $20k 10,000 shares | -5% | +246% from low-29% from high | |
| 25Weak | Gregory James Quarles CEO Emeritus sell | $19k 10,000 shares | -100% | +231% from low-33% from high | |
| 0Weak | Bradford Thomas Adamczyk Executive Chairman sell | $15k 10,000 shares | -1% | +159% from low-47% from high | |
| 10Weak | Stephen William McCahon Chief Science Officer sell | $15k 10,000 shares | -0% | +159% from low-47% from high | |
| 0Weak | Bradford Thomas Adamczyk Executive Chairman sell | $18k 10,000 shares | -1% | +264% from low-36% from high | |
| 13Weak | Christopher Wayne Donaghey President & CEO/Principal AO sell | $20k 10,000 shares | -5% | +302% from low-29% from high | |
| 25Weak | Gregory James Quarles CEO Emeritus sell | $23k 10,000 shares | -100% | +349% from low-21% from high | |
| 0Weak | Bradford Thomas Adamczyk Executive Chairman sell | $23k 10,000 shares | -1% | +353% from low-20% from high | |
| 20Weak | Christopher Wayne Donaghey President & CEO/Principal AO sell | $22k 10,000 shares | -7% | +349% from low-21% from high | |
| 25Weak | Gregory James Quarles CEO Emeritus sell | $22k 10,000 shares | -100% | +339% from low-23% from high | |
| 0Weak | Bradford Thomas Adamczyk Executive Chairman sell | $19k 10,000 shares | -1% | - | |
| 20Weak | Christopher Wayne Donaghey President & CEO/Principal AO sell | $23k 10,000 shares | -7% | - | |
| 25Weak | Gregory James Quarles CEO Emeritus sell | $19k 10,000 shares | -100% | - | |
| 20Weak | Christopher Wayne Donaghey President & CEO/Principal AO sell | $15k 10,000 shares | -6% | - | |
| 0Weak | Bradford Thomas Adamczyk Executive Chairman sell | $15k 10,000 shares | -1% | - |
Transactions
The newest 50 of 76 rows filed, every code.
| Date | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 18, 2026 | Stephen William McCahon Chief Science Officer | GGift Common Stock Purchase Warrantsderivative | -100,000 | - | - | 1,335,000 | 7 d ago |
| Jun 8, 2026 | Bradford Thomas Adamczyk Executive Chairman | MOption exercise Common Stock, par value $0.001 per share10b5-1 | +10,000 | $0.07 | $700 | 681,482 | Jun 10, 2026 |
| Jun 8, 2026 | Bradford Thomas Adamczyk Executive Chairman | SOpen-market sale Common Stock, par value $0.001 per share10b5-1 | -10,000 | $1.50 | $15k | 671,482 | Jun 10, 2026 |
| Jun 8, 2026 | Bradford Thomas Adamczyk Executive Chairman | MOption exercise Non-Qualified Stock Optionsderivative10b5-1 | -10,000 | - | - | 1,300,000 | Jun 10, 2026 |
| Jun 1, 2026 | Christopher Wayne Donaghey President & CEO | SOpen-market sale Common Stock, par value $0.001 per share10b5-1 | -10,000 | $1.50 | $15k | 113,592 | Jun 3, 2026 |
| May 11, 2026 | Bradford Thomas Adamczyk Executive Chairman | MOption exercise Common Stock, par value $0.001 per share10b5-1 | +10,000 | $0.07 | $700 | 681,482 | May 14, 2026 |
| May 11, 2026 | Bradford Thomas Adamczyk Executive Chairman | SOpen-market sale Common Stock, par value $0.001 per share10b5-1 | -10,000 | $1.50 | $15k | 671,482 | May 14, 2026 |
| May 11, 2026 | Bradford Thomas Adamczyk Executive Chairman | MOption exercise Non-Qualified Stock Optionsderivative10b5-1 | -10,000 | - | - | 1,310,000 | May 14, 2026 |
| May 11, 2026 | Christopher Wayne Donaghey President & CEO | SOpen-market sale Common Stock, par value $0.001 per share10b5-1 | -10,000 | $1.50 | $15k | 123,592 | May 13, 2026 |
| Jan 26, 2026 | Christopher Wayne Donaghey President & CEO/Principal AO | SOpen-market sale Common Stock, par value $0.001 per share10b5-1 | -10,000 | $1.65 | $17k | 133,592 | Jan 28, 2026 |
| Jan 21, 2026 | Gregory James Quarles CEO Emeritus | MOption exercise Common Stock, par value $0.001 per share10b5-1 | +6,600 | $0.35 | $2,310 | 6,600 | Jan 23, 2026 |
| Jan 21, 2026 | Gregory James Quarles CEO Emeritus | SOpen-market sale Common Stock, par value $0.001 per share10b5-1 | -6,600 | $1.87 | $12k | 0 | Jan 23, 2026 |
| Jan 21, 2026 | Gregory James Quarles CEO Emeritus | MOption exercise Non-Qualified Stock Optionsderivative10b5-1 | -6,600 | - | - | 4,843,400 | Jan 23, 2026 |
| Jan 20, 2026 | Stephen William McCahon Chief Science Officer | SOpen-market sale Common Stock, par value $0.001 per share10b5-1 | -10,000 | $1.80 | $18k | 12,772,861 | Jan 22, 2026 |
| Jan 7, 2026 | Bradford Thomas Adamczyk Executive Chairman | SOpen-market sale Common Stock, par value $0.001 per share10b5-1 | -10,000 | $1.77 | $18k | 671,482 | Jan 9, 2026 |
| Jan 7, 2026 | Bradford Thomas Adamczyk Executive Chairman | MOption exercise Common Stock, par value $0.001 per share10b5-1 | +10,000 | $0.07 | $700 | 681,482 | Jan 9, 2026 |
| Jan 7, 2026 | Bradford Thomas Adamczyk Executive Chairman | MOption exercise Non-Qualified Stock Optionsderivative10b5-1 | +10,000 | - | - | 1,320,000 | Jan 9, 2026 |
| Dec 26, 2025 | Christopher Wayne Donaghey President & CEO/Principal AO | SOpen-market sale Common Stock, par value $0.001 per share10b5-1 | -2,300 | $1.92 | $4,416 | 151,292 | Dec 30, 2025 |
| Dec 22, 2025 | Stephen William McCahon Chief Science Officer | SOpen-market sale Common Stock, par value $0.001 per share10b5-1 | -10,000 | $1.86 | $19k | 12,782,861 | Dec 30, 2025 |
| Dec 29, 2025 | Christopher Wayne Donaghey President & CEO/Principal AO | SOpen-market sale Common Stock, par value $0.001 per share10b5-1 | -7,700 | $1.93 | $15k | 143,592 | Dec 30, 2025 |
| Dec 22, 2025 | Gregory James Quarles CEO Emeritus | MOption exercise Common Stock, par value $0.001 per share10b5-1 | +10,000 | $0.35 | $3,500 | 10,000 | Dec 29, 2025 |
| Dec 22, 2025 | Gregory James Quarles CEO Emeritus | SOpen-market sale Common Stock, par value $0.001 per share10b5-1 | -10,000 | $1.88 | $19k | 0 | Dec 29, 2025 |
| Dec 22, 2025 | Gregory James Quarles CEO Emeritus | MOption exercise Non-Qualified Stock Optionsderivative10b5-1 | -10,000 | - | - | 4,850,000 | Dec 29, 2025 |
| Dec 8, 2025 | Bradford Thomas Adamczyk Executive Chairman | MOption exercise Common Stock, par value $0.001 per share10b5-1 | +10,000 | $0.07 | $700 | 681,482 | Dec 10, 2025 |
| Dec 8, 2025 | Bradford Thomas Adamczyk Executive Chairman | SOpen-market sale Common Stock, par value $0.001 per share10b5-1 | -10,000 | $1.86 | $19k | 671,482 | Dec 10, 2025 |
| Dec 8, 2025 | Bradford Thomas Adamczyk Executive Chairman | MOption exercise Non-Qualified Stock Optionsderivative10b5-1 | -10,000 | - | - | 1,330,000 | Dec 10, 2025 |
| Dec 4, 2025 | Gregory James Quarles CEO Emeritus | MOption exercise Common Stock, par value $0.001 per share10b5-1 | +10,000 | $0.35 | $3,500 | 10,000 | Dec 8, 2025 |
| Dec 4, 2025 | Gregory James Quarles CEO Emeritus | SOpen-market sale Common Stock, par value $0.001 per share10b5-1 | -10,000 | $1.77 | $18k | 0 | Dec 8, 2025 |
| Dec 4, 2025 | Gregory James Quarles CEO Emeritus | MOption exercise Non-Qualified Stock Optionsderivative10b5-1 | +10,000 | - | - | 4,860,000 | Dec 8, 2025 |
| Nov 28, 2025 | Christopher Wayne Donaghey President & CEO/Principal AO | SOpen-market sale Common Stock, par value $0.001 per share10b5-1 | -10,000 | $1.50 | $15k | 153,592 | Dec 2, 2025 |
| Nov 19, 2025 | Stephen William McCahon Chief Science Officer | SOpen-market sale Common Stock, par value $0.001 per share10b5-1 | -1,100 | $1.50 | $1,650 | 12,801,761 | Nov 21, 2025 |
| Nov 21, 2025 | Stephen William McCahon Chief Science Officer | SOpen-market sale Common Stock, par value $0.001 per share10b5-1 | -8,900 | $1.51 | $13k | 12,792,861 | Nov 21, 2025 |
| Nov 17, 2025 | Bradford Thomas Adamczyk Executive Chairman | MOption exercise Common Stock, par value $0.001 per share10b5-1 | +10,000 | $0.07 | $700 | 681,482 | Nov 19, 2025 |
| Nov 17, 2025 | Bradford Thomas Adamczyk Executive Chairman | SOpen-market sale Common Stock, par value $0.001 per share10b5-1 | -10,000 | $1.58 | $16k | 671,482 | Nov 19, 2025 |
| Nov 17, 2025 | Bradford Thomas Adamczyk Executive Chairman | MOption exercise Non-Qualified Stock Optionsderivative10b5-1 | -10,000 | - | - | 1,340,000 | Nov 19, 2025 |
| Oct 27, 2025 | Christopher Wayne Donaghey President & CEO/Principal AO | SOpen-market sale Common Stock, par value $0.001 per share10b5-1 | -10,000 | $1.68 | $17k | 163,592 | Oct 29, 2025 |
| Oct 20, 2025 | Stephen William McCahon Chief Science Officer | SOpen-market sale Common Stock, par value $0.001 per share10b5-1 | -10,000 | $1.65 | $17k | 12,802,861 | Oct 22, 2025 |
| Sep 25, 2025 | Christopher Wayne Donaghey President & CEO/Principal AO | SOpen-market sale Common Stock, par value $0.001 per share10b5-1 | -10,000 | $2.00 | $20k | 173,592 | Sep 29, 2025 |
| Sep 24, 2025 | Gregory James Quarles CEO Emeritus | MOption exercise Common Stock, par value $0.001 per share10b5-1 | +10,000 | $0.35 | $3,500 | 10,000 | Sep 26, 2025 |
| Sep 24, 2025 | Gregory James Quarles CEO Emeritus | SOpen-market sale Common Stock, par value $0.001 per share10b5-1 | -10,000 | $1.92 | $19k | 0 | Sep 26, 2025 |
| Sep 24, 2025 | Gregory James Quarles CEO Emeritus | MOption exercise Non-Qualified Stock Optionsderivative10b5-1 | -10,000 | - | - | 4,870,000 | Sep 26, 2025 |
| Sep 19, 2025 | Bradford Thomas Adamczyk Executive Chairman | MOption exercise Common Stock, par value $0.001 per share10b5-1 | +10,000 | $0.07 | $700 | 681,482 | Sep 23, 2025 |
| Sep 19, 2025 | Stephen William McCahon Chief Science Officer | SOpen-market sale Common Stock, par value $0.001 per share10b5-1 | -10,000 | $1.50 | $15k | 12,812,861 | Sep 23, 2025 |
| Sep 19, 2025 | Bradford Thomas Adamczyk Executive Chairman | SOpen-market sale Common Stock, par value $0.001 per share10b5-1 | -10,000 | $1.50 | $15k | 671,482 | Sep 23, 2025 |
| Sep 19, 2025 | Bradford Thomas Adamczyk Executive Chairman | MOption exercise Non-Qualified Stock Optionsderivative10b5-1 | -10,000 | - | - | 1,350,000 | Sep 23, 2025 |
| Aug 15, 2025 | Bradford Thomas Adamczyk Executive Chairman | MOption exercise Common Stock, par value $0.001 per share10b5-1 | +10,000 | $0.07 | $700 | 681,482 | Aug 19, 2025 |
| Aug 15, 2025 | Bradford Thomas Adamczyk Executive Chairman | SOpen-market sale Common Stock, par value $0.001 per share10b5-1 | -10,000 | $1.76 | $18k | 671,482 | Aug 19, 2025 |
| Aug 15, 2025 | Bradford Thomas Adamczyk Executive Chairman | MOption exercise Non-Qualified Stock Optionsderivative10b5-1 | -10,000 | - | - | 1,360,000 | Aug 19, 2025 |
| Aug 5, 2025 | Christopher Wayne Donaghey President & CEO/Principal AO | SOpen-market sale Common Stock, par value $0.001 per share10b5-1 | -10,000 | $1.98 | $20k | 183,592 | Aug 8, 2025 |
| Jul 21, 2025 | Gregory James Quarles CEO Emeritus | MOption exercise Common Stock, par value $0.001 per share10b5-1 | +10,000 | $0.35 | $3,500 | 10,000 | Jul 22, 2025 |
Insiders
Everyone who has filed a Form 4 here.
- Bradford Thomas AdamczykExecutive Chairman
- Christopher Wayne DonagheyPresident & CEO
- Stephen William McCahonChief Science Officer
- Gregory James QuarlesCEO Emeritus
Questions about AERG
Answered from the filings on this page, as of the latest one.
Are insiders buying AERG?
No. In the last 90 days no insider at APPLIED ENERGETICS, INC. bought or sold shares on the open market according to SEC Form 4 filings. The rows on file from that period are grants, exercises, tax withholding or other transactions, which carry no view on the price.
Who was the last insider to trade AERG on the open market?
Bradford Thomas Adamczyk (Executive Chairman) sold $15k of AERG on Jun 8, 2026 and filed the Form 4 on Jun 10, 2026. InsiderTell scored 0 (weak), under a 10b5-1 plan, with 2 insiders on the same side within 14 days.
How many insiders file Form 4 at APPLIED ENERGETICS, INC.?
4 people have filed a Form 4 at APPLIED ENERGETICS, INC., among them Bradford Thomas Adamczyk (Executive Chairman), Christopher Wayne Donaghey (President & CEO), Stephen William McCahon (Chief Science Officer). Officers, directors and holders of more than 10% of a share class must report their trades within two business days.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.